Qurient

Innovation for
Unmet
Medical
Needs

Global Leader
of Network
R&D

Clinical & non-clinical
pipeline with
Global
standard

Notice

2023-11-27	“큐리언트, 후보물질 가능성을 고려한 꾸준한 연구개발이 경쟁력”
2023-11-16	큐리언트, ‘TOP1 ADC+CDK7 병용’ 추진..메커니즘은?
2023-11-07	큐리언트, SITC서 ‘Axl/Mer/CSF1R 저해제’ 1상 발표
2023-11-07	"치료제 없던 소세포폐암 신약…내년 빅파마에 기술수출 기대"
2023-11-06	큐리언트, 바이오 유럽 참가…항암치료제 기술수출 가속화

Company

Founded in 2008, Qurient takes a pioneering position in the newly emerging biotech industry in Korea. Qurient introduced a unique virtual biotech model, running R&D operations not only in clinical development phases, but also in early discovery research stage, named ‘Network R&D’ model.See More
Business philosophy

Innovation for unmet medical needs

Qurient’s mission is to provide innovation for unmet medical needs to help patients around the world. Through fulfilling the mission, Qurient will be able to create concrete value for its shareholders. See More
Pipeline

Qurient portfolio plan aims to achieve balanced innovation by strategic positioning of the R&D programs.See More
IR/PR

Dear Qurient shareholders

Qurient would like to share brief updates on current progress made on its portfolio programs. See More